3-甲氧基-25-二甲基吡嗪 | 19846-22-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 3-甲氧基-25-二甲基吡嗪
• 英文名称: 3-methoxyl-2,5-dimethylpyrazine
• 英文别名: 2-methoxy-3,6-dimethylpyrazine；3,6-dimethyl-2-methoxypyrazine；3-methoxy-2,5-dimethylpyrazine；3-methoxy-2,5-dimethyl-pyrazine；2,5-dimethyl-3-methoxypyrazine；3-Methoxy-2,5-dimethyl-pyrazin
• CAS: 19846-22-1
• 化学式: C₇H₁₀N₂O
• mdl: MFCD28162737
• 分子量: 138.169
• InChiKey: QYRGVELVPYDICQ-UHFFFAOYSA-N

物化性质

• 沸点：
  179.3±35.0 °C(Predicted)
• 密度：
  1.043±0.06 g/cm3(Predicted)
• LogP：
  1.670 (est)
• 保留指数：
  1054;1057;1065

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.428
• 拓扑面积：
  35
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335

反应信息

• 作为反应物：
  描述：

  3-甲氧基-25-二甲基吡嗪 在 碳酸氢钠 、 三氯氧磷 作用下， 反应 3.0h， 生成 1-chloro-3-methyl-7-phenylpyrrolo<1,2-a>pyrazine
  参考文献：
  名称：

  The Synthesis of Pyrrolo[1,2-a]pyrazin-1(2H)-ones and Pyrrolo[1,2-b]pyridazin-6(5H)-ones

  摘要：

  The pyrrolo[1,2-a]pyrazin-1(2H)-ones (10), (11), (12) and (13) and the pyrrolo[1,2-b[pyridazin-6(5H)-one (18) were prepared either a) directly by Chichibabin quaternisation-cyclisation of the corresponding methoxy-methylpyrazine or pyridazine or b) by hydrogen halide hydrolysis of methoxypyrrolo[1,2-a]pyrazines and methoxypyrrolo[1,2-b]pyridazines. Protonation studies and some reactivity of the systems are discussed.

  DOI：

  10.3987/com-92-6085
• 作为产物：
  描述：

  甲醇 、 3-氯-2,5-二甲基吡嗪 在 sodium methylate 作用下， 反应 2.0h， 生成 3-甲氧基-25-二甲基吡嗪
  参考文献：
  名称：

  Potent Odorants of Raw Arabica Coffee. Their Changes during Roasting

  摘要：

  Aroma extract dilution analysis of raw Arabica coffee revealed 3-isobutyl-2-methoxypyrazine (I), 2-methexy-3,5-dimethylpyrazine (II), ethyl 2-methylbutyrate (III), ethyl 3-methylbutyrate (IV), and 3-isopropyl-2-methoxypyrazine (V) as potent odorants. The highest odor activity value was found for I followed by II, IV, and V. It was concluded that I was responsible for the characteristic, peasy odor note of raw coffee. Twelve odorants occurring in raw coffee and (E)-beta-damascenone were also quantified after roasting. The concentration of I did not change, whereas methional, 3-hydroxy-4,5-direethyl-2(5H)-furanone, vanillin, (E)-beta-damascenone, and 4-vinyl- and 4-ethylguaiacol increased strongly during the roasting process.

  DOI：

  10.1021/jf990609n

文献信息

• [EN] TRIAZOLE AGONISTS OF THE APJ RECEPTOR<br/>[FR] TRIAZOLES AGONISTES DU RÉCEPTEUR APJ
  申请人：AMGEN INC

  公开号：WO2016187308A1

  公开（公告）日：2016-11-24

  Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures where the definitions of the variables are provided herein.

  公式I和公式II的化合物，其药用盐，上述任何一种的立体异构体，或它们的混合物是APJ受体的激动剂，并可用于治疗心血管和其他疾病。公式I和公式II的化合物具有以下结构，其中变量的定义在此提供。
• [EN] TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR<br/>[FR] COMPOSÉS DE TRIAZOLE PYRIDYLE EN TANT QU'AGONISTES DU RÉCEPTEUR APJ
  申请人：AMGEN INC

  公开号：WO2018093580A1

  公开（公告）日：2018-05-24

  Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein.

  化合物I和化合物II，其药用可接受盐，上述任何的立体异构体，或它们的混合物是APJ受体的激动剂，可能用于治疗心血管和其他疾病。化合物I和化合物II的结构如下，其中变量的定义在此处提供。
• 8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE DERIVATIVE
  申请人：Horiuchi Yoshihiro

  公开号：US20120225876A1

  公开（公告）日：2012-09-06

  Disclosed is a compound represented by formula (1) or a pharmacologically acceptable salt thereof (In the formula, A represents a group that is represented by formula (A-1); R 1a and R 1b may be the same or different and each independently represents a C 1-6 alkyl group which may be substituted by one to three halogen atoms; m and n each independently represents an integer of 0-5; X 1 represents a hydroxyl group or an aminocarbonyl group; Z 1 represents a single bond or the like; and R 2 represents an optionally substituted C 1-6 alkyl group, an optionally substituted C 6-10 aryl group or the like.)

  公开了一种由公式(1)表示的化合物或其药理可接受的盐(在公式中，A代表由公式(A-1)表示的基团；R1a和R1b可以相同或不同，每个独立地表示一个可以由一个到三个卤素原子取代的C1-6烷基；m和n各自独立地表示0-5之间的整数；X1代表羟基或氨基甲酰基；Z1代表单键等；R2代表一个可选地取代的C1-6烷基，一个可选地取代的C6-10芳基等)。
• Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities
  申请人：Shionogi & Co., Ltd.

  公开号：US06756376B1

  公开（公告）日：2004-06-29

  The present invention provides a compound having sPLA2 inhibiting activity. The compound represented by the formula (I): wherein E is N or C—R4; G is N or C—R25; R1 is a carbocyclic group, heterocyclic group or the like; one of R3 and R4 is —(L2)-(acidic group), the other is a hydrogen atom, wherein L2 is a group connecting with an acid group; A ring is optionally substituted 5-8 membered cyclohexane ring or cyclohexene ring; R24 and R25 are a hydrogen atom or the like, its prodrug, their pharmaceutically acceptable salt, or hydrate thereof.

  本发明提供了一种具有sPLA2抑制活性的化合物。该化合物由式(I)表示：其中E为N或C—R4；G为N或C—R25；R1为碳环族、杂环族或类似物；R3和R4中的一个为—(L2)-(酸性基团)，另一个为氢原子，其中L2为与酸基团连接的基团；环A可选地取代的5-8成员环己烷环或环己烯环；R24和R25为氢原子或类似物，其前药、它们的药学上可接受的盐或其水合物。
• TRIAZOLE AGONISTS OF THE APJ RECEPTOR
  申请人：AMGEN INC.

  公开号：US20170044131A1

  公开（公告）日：2017-02-16

  Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.

  公式I和公式II的化合物，其药用可接受的盐，任何上述的立体异构体，或其混合物均为APJ受体激动剂，并可用于治疗心血管和其他疾病。公式I和公式II的化合物具有以下结构：其中变量的定义在此处提供。

表征谱图